Free Trial

Spectral AI (MDAI) Stock Price, News & Analysis

-0.05 (-2.98%)
(As of 05/23/2024 ET)
Today's Range
50-Day Range
52-Week Range
290,128 shs
Average Volume
1.47 million shs
Market Capitalization
$28.48 million
P/E Ratio
Dividend Yield
Price Target

Spectral AI MarketRank™ Stock Analysis

Analyst Rating
3.00 Rating Score
145.4% Upside
$4.00 Price Target
Short Interest
3.13% of Float Sold Short
Dividend Strength
News Sentiment
0.33mentions of Spectral AI in the last 14 days
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
$10,320 Bought Last Quarter
Proj. Earnings Growth

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.02 out of 5 stars

Medical Sector

171st out of 916 stocks

Surgical & Medical Instruments Industry

22nd out of 93 stocks

MDAI stock logo

About Spectral AI Stock (NASDAQ:MDAI)

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.

MDAI Stock Price History

MDAI Stock News Headlines

Spectral AI, Inc. (MDAI)
Spectral AI appoints Erich Spangenberg as CEO of Spectral IP
See More Headlines
Receive MDAI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Spectral AI and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Surgical & medical instruments
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
1 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$18.06 million
Book Value
($0.12) per share


Free Float
Market Cap
$28.48 million
Not Optionable
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Wensheng Fan (Age 54)
    Co-Founder, Chief Innovation Strategist & Senior Advisor to the CEO
    Comp: $978.63k
  • Mr. Vincent Stanley Capone (Age 57)
    CFO, General Counsel & Corporate Secretary
    Comp: $430.87k
  • Ms. Christine Marks
    Vice President of Marketing & Commercialization
  • Mr. Peter Martin Carlson CPA (Age 60)
    CEO & Director
  • Mr. Stan Micek
    Interim Chief Operating Officer
  • Dr. Jeffrey Thatcher Ph.D. (Age 40)
    Chief Scientist
    Comp: $259.72k
  • Dr. Jeffrey E. Carter F.A.C.S.
    M.D., Chief Medical Consultant
  • Mr. Erich L. Spangenberg (Age 62)
    CEO of its Health care & Director
    Comp: $37.02k
  • Prof. Paul Chadwick
    Executive Vice President of UK & EMEA
  • Mr. Jeremiah A. Sparks MBA
    Chief Commercialization Officer

MDAI Stock Analysis - Frequently Asked Questions

Should I buy or sell Spectral AI stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Spectral AI in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" MDAI shares.
View MDAI analyst ratings
or view top-rated stocks.

What is Spectral AI's stock price target for 2024?

1 brokers have issued 12 month target prices for Spectral AI's shares. Their MDAI share price targets range from $4.00 to $4.00. On average, they anticipate the company's share price to reach $4.00 in the next twelve months. This suggests a possible upside of 145.4% from the stock's current price.
View analysts price targets for MDAI
or view top-rated stocks among Wall Street analysts.

How have MDAI shares performed in 2024?

Spectral AI's stock was trading at $2.46 at the beginning of 2024. Since then, MDAI shares have decreased by 33.7% and is now trading at $1.63.
View the best growth stocks for 2024 here

When is Spectral AI's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 6th 2024.
View our MDAI earnings forecast

How were Spectral AI's earnings last quarter?

Spectral AI, Inc. (NASDAQ:MDAI) released its earnings results on Friday, March, 29th. The company reported ($0.22) EPS for the quarter. The company earned $5.29 million during the quarter.

What guidance has Spectral AI issued on next quarter's earnings?

Spectral AI issued an update on its FY 2024 earnings guidance on Friday, April, 19th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $28.0 million-$28.0 million, compared to the consensus revenue estimate of $28.1 million.

Who are Spectral AI's major shareholders?

Spectral AI's stock is owned by a variety of retail and institutional investors. Top institutional investors include University of Texas Texas AM Investment Managment Co. (1.20%), Murchinson Ltd. (0.23%) and Virtu Financial LLC (0.10%).
View institutional ownership trends

How do I buy shares of Spectral AI?

Shares of MDAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:MDAI) was last updated on 5/23/2024 by Staff

From Our Partners